Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention
Clinical trial NCT03817125 · COMPLETED
Trial details
- NCT number
- NCT03817125
- Sponsor
- Parker Institute for Cancer Immunotherapy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2022-03-04
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.